114 related articles for article (PubMed ID: 10822764)
1. [Transfusion related graft versus host disease. Indications for irradiated blood components].
Muñiz-Díaz E; Martínez Valverde C; Sierra J; Madoz P
Sangre (Barc); 1999 Dec; 44(6):483-8. PubMed ID: 10822764
[No Abstract] [Full Text] [Related]
2. Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force.
Treleaven J; Gennery A; Marsh J; Norfolk D; Page L; Parker A; Saran F; Thurston J; Webb D
Br J Haematol; 2011 Jan; 152(1):35-51. PubMed ID: 21083660
[No Abstract] [Full Text] [Related]
3. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
[No Abstract] [Full Text] [Related]
4. [Transfusion-associated graft-versus-host disease guideline on gamma irradiation of blood components].
Landi EP; de Oliveira JS
Rev Assoc Med Bras (1992); 1999; 45(3):261-72. PubMed ID: 10513059
[TBL] [Abstract][Full Text] [Related]
5. [Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma].
García Gala JM; Ramírez Páyer A; Rayón C; Rodríguez Vicente P; Rosón C; Blanco C
Sangre (Barc); 1993 Dec; 38(6):489-91. PubMed ID: 8171385
[TBL] [Abstract][Full Text] [Related]
6. Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors.
Shivdasani RA; Haluska FG; Dock NL; Dover JS; Kineke EJ; Anderson KC
N Engl J Med; 1993 Mar; 328(11):766-70. PubMed ID: 8437597
[No Abstract] [Full Text] [Related]
7. Transfusion of blood components to infants under four months: review and guidelines.
O'Riordan JM; Fitzgerald J; Smith OP; Bonnar J; Gorman WA;
Ir Med J; 2007 Jun; 100(6):suppl 1-24 following 496. PubMed ID: 17668683
[No Abstract] [Full Text] [Related]
8. Residual immunological risks associated with red blood cell transfusion.
Rouger P; Le Pennec PY
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):217-9. PubMed ID: 8337131
[No Abstract] [Full Text] [Related]
9. Leukocyte-reduced blood components in transfusion medicine. Current indications and prospects for the future.
Klapper EB; Goldfinger D
Clin Lab Med; 1992 Dec; 12(4):711-21. PubMed ID: 1286560
[TBL] [Abstract][Full Text] [Related]
10. Transfusion associated graft versus host disease.
Gupta A; Bansal D; Dass R; Das A
Indian Pediatr; 2004 Dec; 41(12):1260-4. PubMed ID: 15623910
[TBL] [Abstract][Full Text] [Related]
11. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
[No Abstract] [Full Text] [Related]
12. Chronic graft-versus-host disease following allogeneic peripheral blood and bone marrow stem cell transplants: a single center experience.
Takami A; Ishiyama K; Asakura H; Shiobara S; Nakao S
Haematologica; 2002 Jun; 87(6):664-6. PubMed ID: 12031928
[No Abstract] [Full Text] [Related]
13. Gamma-irradiation of blood products following autologous stem cell transplantation: surveillance of the policy of 35 centers.
Weiss B; Hoffmann M; Anders C; Hellstern P; Schmitz N; Uppenkamp M;
Ann Hematol; 2004 Jan; 83(1):44-9. PubMed ID: 14551741
[TBL] [Abstract][Full Text] [Related]
14. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
15. Transfusion-associated graft-versus-host disease in ataxia telangiectasia.
Watson HG; McLaren KM; Todd A; Wallace WH
Lancet; 1997 Jan; 349(9046):179. PubMed ID: 9111549
[No Abstract] [Full Text] [Related]
16. Use of irradiated blood components: practice parameter.
Przepiorka D; LeParc GF; Stovall MA; Werch J; Lichtiger B
Am J Clin Pathol; 1996 Jul; 106(1):6-11. PubMed ID: 8701934
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.
Agbaht K; Altintas ND; Topeli A; Gokoz O; Ozcebe O
Transfusion; 2007 Aug; 47(8):1405-11. PubMed ID: 17655584
[TBL] [Abstract][Full Text] [Related]
18. Atypical, nonfatal, transfusion-associated, acute graft-versus-host disease in a patient with Hodgkin's disease.
Held JL; Druker BJ; Kohn SR; Byrnes W; Margolis RJ
J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):261-2. PubMed ID: 1552066
[No Abstract] [Full Text] [Related]
19. Transfusion-associated graft-versus-host disease.
Dwyre DM; Holland PV
Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
[TBL] [Abstract][Full Text] [Related]
20. Irradiation eradication and pathogen reduction. Ceasing cesium irradiation of blood products.
Mintz PD; Wehrli G
Bone Marrow Transplant; 2009 Aug; 44(4):205-11. PubMed ID: 19617907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
